We are committed to discovering, developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with serious and life-threatening conditions. Basilea is headquartered in Basel, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN).
CEO David Veitch | Half-year 2019 Update
Play
News
Dec 06. 2019
Oct 30. 2019
Oct 29. 2019
Half-year Report 2019
CEO Statement
For the benefit of patients around the world, we are continuing to establish Cresemba and Zevtera as truly global brands. In addition, by strengthening our pre-clinical and clinical oncology pipeline, we aim to become a leading provider of innovative cancer therapies in the future.

Facts & Figures



Located in the heart of the life-sciences hub Basel
Play